Strides Pharma Science Limited

NSEI:STAR Lagerbericht

Marktkapitalisierung: ₹79.1b

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Strides Pharma Science Management

Management Kriterienprüfungen 2/4

Strides Pharma Science's CEO ist Arun Pillai, ernannt in Apr 2022, hat eine Amtszeit von 2.08 Jahren. Die jährliche Gesamtvergütung beträgt ₹60.00M, bestehend aus 0% Gehalt und 100% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 2.11% der Aktien des Unternehmens, im Wert von ₹1.67B. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 4.7 Jahre bzw. 8.4 Jahre.

Wichtige Informationen

Arun Pillai

Geschäftsführender

₹60.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts0.0%
Amtszeit als Geschäftsführer2.1yrs
Eigentum des Geschäftsführers2.1%
Durchschnittliche Amtszeit des Managements4.7yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder8.4yrs

Jüngste Management Updates

Recent updates

Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)

Apr 04
Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Feb 29
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

Dec 23
Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Sep 26
We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Jun 08
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Aug 02
Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Jun 25
Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Dec 21
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Jul 28
Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Apr 13
Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

Mar 04
Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Feb 15
These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

Jan 26
Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Jan 11
The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?

Dec 28
Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?

Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 10
Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?

Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?

Nov 25
Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Arun Pillai im Vergleich zu den Einnahmen von Strides Pharma Science verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2024n/an/a

-₹1b

Dec 31 2023n/an/a

-₹2b

Sep 30 2023n/an/a

-₹2b

Jun 30 2023n/an/a

-₹924m

Mar 31 2023₹60m₹1

-₹2b

Dec 31 2022n/an/a

-₹2b

Sep 30 2022n/an/a

-₹2b

Jun 30 2022n/an/a

-₹4b

Mar 31 2022₹800kn/a

-₹5b

Dec 31 2021n/an/a

-₹4b

Sep 30 2021n/an/a

-₹3b

Jun 30 2021n/an/a

-₹543m

Mar 31 2021₹8mn/a

₹3b

Dec 31 2020n/an/a

₹28m

Sep 30 2020n/an/a

₹589m

Jun 30 2020n/an/a

₹1b

Mar 31 2020₹72m₹49m

₹492m

Dec 31 2019n/an/a

₹3b

Sep 30 2019n/an/a

₹2b

Jun 30 2019n/an/a

₹745m

Mar 31 2019₹50m₹38m

₹840m

Dec 31 2018n/an/a

-₹93m

Sep 30 2018n/an/a

₹139m

Jun 30 2018n/an/a

₹415m

Mar 31 2018₹106m₹14m

₹544m

Vergütung im Vergleich zum Markt: ArunDie Gesamtvergütung ($USD722.28K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD382.73K).

Entschädigung vs. Einkommen: ArunDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

Arun Pillai (62 yo)

2.1yrs

Amtszeit

₹60,000,001

Vergütung

Mr. Arun Kumar Pillai, B.Com., is Founder of Solara Active Pharma Sciences Limited and serves as its Non-Executive Director since August 04, 2021 and its Founder. Mr. Pillai has been Executive Chairperson...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Arun Pillai
Founder2.1yrs₹60.00m2.11%
₹ 1.7b
Badree Komandur
Group CFO10.8yrs₹44.00m0.027%
₹ 21.5m
Manjula Ramamurthy
Compliance Officer & Company Secretary7.3yrs₹5.86mkeine Daten
P. V. Ramaraju
Chief Operating Officerless than a yearkeine Datenkeine Daten
Sormistha Ghosh
Group General Counsel & Chief Risk Officerno datakeine Datenkeine Daten
Surabhi Loshali
Senior VP of Human Resourcesno datakeine Datenkeine Daten
C. Sundar
Executive Vice President of Operationsno datakeine Datenkeine Daten
Kevin Cook
Senior Vice President of Strides Pharma Inc.no datakeine Datenkeine Daten
Umesh Kale
Chief Quality Officerno datakeine Datenkeine Daten
A. Narayanan
Chief Information Technology Officerno datakeine Datenkeine Daten
Vinod Nair
Senior Vice President of Institutional Businessno datakeine Datenkeine Daten
Amol Mehta
Senior Vice President of Regulated Marketsno datakeine Datenkeine Daten

4.7yrs

Durchschnittliche Betriebszugehörigkeit

51yo

Durchschnittliches Alter

Erfahrenes Management: STARDas Führungsteam des Unternehmens gilt als erfahren (4.7 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Arun Pillai
Founder33.9yrs₹60.00m2.11%
₹ 1.7b
Badree Komandur
Group CFO7yrs₹44.00m0.027%
₹ 21.5m
Homi Khusrokhan
Independent Director7yrs₹2.20mkeine Daten
Srinivasan Sridhar
Independent Director11.8yrs₹2.20mkeine Daten
Dennis Bastas
Executive Chairman of Arrow Pharmaceuticals Pty Ltdno datakeine Datenkeine Daten
Gopakumar Nair
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Elias Neto
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
S. Vyas
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
B. Suresh
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
C. Gupta
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Bharat Shah
Independent Director9.8yrs₹2.20m0.083%
₹ 65.8m
Kausalya Santhanam
Independent Director4.4yrs₹2.20m0.0013%
₹ 1.0m

8.4yrs

Durchschnittliche Betriebszugehörigkeit

72yo

Durchschnittliches Alter

Erfahrener Vorstand: STARDie Vorstandsmitglieder gelten als erfahren (8.4 Jahre durchschnittliche Amtszeit).